This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why 3D Systems Will Revolutionize Manufacturing

By John Linnemeier

I'm hanging tough with my holdings in 3D Systems (DDD) and the iShares Nasdaq Biotech ETF (IBB). My reasons are pretty straightforward.

I personally believe 3D-printing is going to revolutionize manufacturing on Earth. We've only seen the beginning. This specific company is the leader in the field. There's nothing blue sky about it.

The company turns a profit, and I believe will soon even pay a small dividend. The market is absurdly manic-depressive in its appraisal of this equity. I have no idea what's going to happen to this stock over the short-term... nor does anybody else. Over the long-term, though, it's the best bet I know, and that's why I'm loaded up with it.

IBB, the ETF for the NASDAQ Biotechnology Index, is my second holding. Trying to pick the winners and avoid the losers in biotechnology is practically impossible for someone without inside information. On the other hand, the field as a whole is finally beginning to bear fruit, and the future appears very bright. This is a way for me to diversify. That's my rationale.

The investments discussed are held in client accounts as of May 31, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable.

John Linnemeier

John Linnemeier

I'm a writer. The book "How an Average Man Lived an Adventurous Life" is my autobiography. I've spent much of

null

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,949.59 -85.34 -0.47%
S&P 500 2,097.29 -3.11 -0.15%
NASDAQ 5,014.1020 +19.50 0.39%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs